| Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data G Leandro, A Mangia, J Hui, P Fabris, L Rubbia–Brandt, G Colloredo, ... Gastroenterology 130 (6), 1636-1642, 2006 | 680 | 2006 |
| The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype‐specific mechanisms V Pazienza, S Clément, P Pugnale, S Conzelman, M Foti, A Mangia, ... Hepatology 45 (5), 1164-1171, 2007 | 281 | 2007 |
| Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies C Panebianco, A Andriulli, V Pazienza Microbiome 6, 1-13, 2018 | 257 | 2018 |
| An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation K Abid, V Pazienza, A de Gottardi, L Rubbia-Brandt, B Conne, P Pugnale, ... Journal of hepatology 42 (5), 744-751, 2005 | 208 | 2005 |
| Clock genes and clock-controlled genes in the regulation of metabolic rhythms G Mazzoccoli, V Pazienza, M Vinciguerra Chronobiology international 29 (3), 227-251, 2012 | 193 | 2012 |
| Analysis of gut microbiota in rheumatoid arthritis patients: disease-related dysbiosis and modifications induced by etanercept A Picchianti-Diamanti, C Panebianco, S Salemi, ML Sorgi, R Di Rosa, ... International journal of molecular sciences 19 (10), 2938, 2018 | 186 | 2018 |
| Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients G Mazzoccoli, A Panza, MR Valvano, O Palumbo, M Carella, V Pazienza, ... Chronobiology international 28 (10), 841-851, 2011 | 183 | 2011 |
| Mirna expression profiles identify drivers in colorectal and pancreatic cancers A Piepoli, F Tavano, M Copetti, T Mazza, O Palumbo, A Panza, FF Di Mola, ... PloS one 7 (3), e33663, 2012 | 180 | 2012 |
| Peroxisome proliferator‐activated receptor‐α and ‐γ mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection A De Gottardi, V Pazienza, P Pugnale, F Bruttin, L Rubbia‐Brandt, ... Alimentary pharmacology & therapeutics 23 (1), 107-114, 2006 | 153 | 2006 |
| IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection A Mangia, R Santoro, M Piattelli, V Pazienza, G Grifa, A Iacobellis, ... Cytokine 25 (3), 103-109, 2004 | 151 | 2004 |
| mIGF‐1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart M Vinciguerra, MP Santini, C Martinez, V Pazienza, WC Claycomb, ... Aging cell 11 (1), 139-149, 2012 | 137 | 2012 |
| ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer G Mazzoccoli, V Pazienza, A Panza, MR Valvano, G Benegiamo, ... Journal of cancer research and clinical oncology 138, 501-511, 2012 | 133 | 2012 |
| Impact of different types of diet on gut microbiota profiles and cancer prevention and treatment RJ Klement, V Pazienza Medicina 55 (4), 84, 2019 | 132 | 2019 |
| Hepatitis delta virus inhibits alpha interferon signaling P Pugnale, V Pazienza, K Guilloux, F Negro Hepatology 49 (2), 398-406, 2009 | 129 | 2009 |
| Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD) C Podrini, M Borghesan, A Greco, V Pazienza, G Mazzoccoli, ... Current pharmaceutical design 19 (15), 2737-2746, 2013 | 114 | 2013 |
| Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells B Sigala, C McKee, J Soeda, V Pazienza, M Morgan, CI Lin, C Selden, ... PloS one 8 (9), e72928, 2013 | 96 | 2013 |
| Monocyte chemoattractant protein‐1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes S Clément, C Juge‐Aubry, A Sgroi, S Conzelmann, V Pazienza, ... Hepatology 48 (3), 799-807, 2008 | 95 | 2008 |
| Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings C Panebianco, JA Oben, M Vinciguerra, V Pazienza Clinical and experimental medicine 17, 269-280, 2017 | 92 | 2017 |
| Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models M D'Aronzo, M Vinciguerra, T Mazza, C Panebianco, C Saracino, ... Oncotarget 6 (21), 18545, 2015 | 92 | 2015 |
| Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice C Panebianco, K Adamberg, M Jaagura, M Copetti, A Fontana, ... Cancer chemotherapy and pharmacology 81, 773-782, 2018 | 86 | 2018 |
